BeOne Medicines (NASDAQ:ONC – Get Free Report) and Sunshine Biopharma (NASDAQ:SBFM – Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, risk and profitability.
Valuation & Earnings
This table compares BeOne Medicines and Sunshine Biopharma”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| BeOne Medicines | $5.34 billion | 7.36 | $286.93 million | $5.68 | 63.07 |
| Sunshine Biopharma | $36.31 million | 0.12 | -$5.97 million | ($10.15) | -0.11 |
Risk & Volatility
BeOne Medicines has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500. Comparatively, Sunshine Biopharma has a beta of 1.17, meaning that its share price is 17% more volatile than the S&P 500.
Institutional & Insider Ownership
48.5% of BeOne Medicines shares are held by institutional investors. Comparatively, 42.0% of Sunshine Biopharma shares are held by institutional investors. 6.2% of BeOne Medicines shares are held by insiders. Comparatively, 0.5% of Sunshine Biopharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Analyst Ratings
This is a breakdown of current ratings and recommmendations for BeOne Medicines and Sunshine Biopharma, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| BeOne Medicines | 1 | 1 | 12 | 3 | 3.00 |
| Sunshine Biopharma | 1 | 1 | 1 | 0 | 2.00 |
BeOne Medicines currently has a consensus target price of $402.14, suggesting a potential upside of 12.25%. Sunshine Biopharma has a consensus target price of $70.00, suggesting a potential upside of 6,040.35%. Given Sunshine Biopharma’s higher probable upside, analysts plainly believe Sunshine Biopharma is more favorable than BeOne Medicines.
Profitability
This table compares BeOne Medicines and Sunshine Biopharma’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| BeOne Medicines | 10.70% | 14.23% | 7.82% |
| Sunshine Biopharma | -17.94% | -26.36% | -20.60% |
Summary
BeOne Medicines beats Sunshine Biopharma on 13 of the 15 factors compared between the two stocks.
About BeOne Medicines
BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.
About Sunshine Biopharma
Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine Biopharma, Inc. is headquartered in New York, New York.
Receive News & Ratings for BeOne Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeOne Medicines and related companies with MarketBeat.com's FREE daily email newsletter.
